Nasdaq Biotech Index Gains As Genta, Encysive Lead

The NBI ended trading today up 0.26% to 747.55

Genta Inc. (GNTA) gained more than 18% today as the company announced the publication of its Genasense phase 3 trial for Melanoma in the Journal of Clinical Oncology showed some positive results.

Encysive Pharmaceuticals Inc. (ENCY) ended trading up more than 10% on a late surge in volume with no press release. It would be interesting to watch if the company will post news on Monday.

Hollis-Eden Pharmaceuticals Inc. (HEPH) lost more than 8% on the day on large volume as the stock's volatility over the summer months continues into the fall. The stock has had large moves downward on big volume a few times over the last couple of months despite presenting positive data on Wednesday regarding its prostate cancer drug.